NLS Pharmaceutics Announces Positive Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with Narcolepsy
Press release content from Accesswire. The AP news staff was not involved in its creation.
Source: apnews.com
Stay updated with breaking news from Tolerability Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Oral presentation to discuss new data updates from the high- and low-dose cohorts from the ongoing Phase 1/2 trial of AXO-AAV-GM1 for the treatment of GM1...